Reverse-FOIA limitations on agency actions to disclose human gene therapy clinical trial data.
Food and Drug Law Journal 2008; 63(1): 321-373
Showing items related by title, author, creator and subject.
French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy European Society of Gene Therapy [ESGT] (2003-01)